Heterogeneity of breast cancer I stage: clinical and prognostic value of the carcinoma size T1A, T1B and T1C
- 作者: Kolyadina I.1,2, Poddubnaya I.1,2, Trofimova O.2, Frank G.1, Komov D.2, Karseladze A.2, Ozhereliev A.2
-
隶属关系:
- Russian Medical Academy of Postgraduate Education
- N.N. Blokhin Russian Cancer Research Center
- 期: 卷 20, 编号 1 (2015)
- 页面: 17-22
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40107
- DOI: https://doi.org/10.17816/onco40107
- ID: 40107
如何引用文章
全文:
详细
作者简介
Irina Kolyadina
Russian Medical Academy of Postgraduate Education; N.N. Blokhin Russian Cancer Research Center
Email: irinakolyadina@yandex.ru
MD, PhD 123995, Moscow, Russian Federation
I. Poddubnaya
Russian Medical Academy of Postgraduate Education; N.N. Blokhin Russian Cancer Research Center123995, Moscow, Russian Federation
O. Trofimova
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
G. Frank
Russian Medical Academy of Postgraduate Education123995, Moscow, Russian Federation
D. Komov
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
A. Karseladze
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
A. Ozhereliev
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
参考
- GLOBOGAN 2012; www.http://globocan.iarc.fr
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2013 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2014. www.
- Аксель Е.М. Заболеваемость и смертность от рака молочной железы в России. В кн.: Материалы большой конференции RUSSCO «Рак молочной железы» 22-24 января 2014 г. М.; 2014: 35-8.
- Livi L., Meattini I., Saieva C. et al. Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. Cancer2012; 118 (13): 3236-43.
- Gonzalez-Angulo A.M., Litton J.K., Broglio K.R. et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J. Clin. Oncol. 2009; 27 (34): 5700-6.
- Schroeder M.C., Lynch C.F., Abu-Hejleh T. et al. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010-2012. Clin. Breast Cancer. 2014 Aug 18. pii: S1526-8209(14)00164-5.
- Harbeck N., Thomssen Ch., Gnant M. Brief Preliminary Summary of the Consensus Discussion. Breast Care (Basel). 2013; 8 (2): 102-9.
- NCCN breast cancer guidelines professionals http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#breast
- Schroeder M.C., Lynch C.F., Abu-Hejleh T., Chrischilles E. A., Thomas A. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010-2012. Clin. Breast Cancer. 2014; 18. pii: S1526-8209 (14): 164-5.
- Langagergaard V, Garne J.P., Vejborg I., Schwartz W., Bak M., Lernevall A. et al. Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening. Clin Epidemiol. 2013; 5: 81-8.